Distinguishing COVID-19 from influenza with rapid 15-minute diagnostics

  • Funded by Health Research Council of New Zealand
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $119,907.7
  • Funder

    Health Research Council of New Zealand
  • Principal Investigator

    Mr. John Mackay
  • Research Location

    New Zealand
  • Lead Research Institution

    Dnature Diagnostics & Research
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Diagnostic testing is critical for the containment of COVID-19 and other infectious diseases. Due to the current complexity of the tests and thus capacity limits, testing is typically limited to those meeting certain threshold criteria. In addition, test results may take up to 48 hours to be returned to parts of New Zealand by the time samples reach the lab, the work is completed, and the results returned. Therefore, the danger exists that a disease will spread faster than the testing can help isolate positive cases. This work aims to develop rapid (15minute) molecular diagnostics that can be performed anywhere without the need for DNA instrumentation. Results will be collected and reported centrally via a smart phone app for further follow-up and confirmation. Such a method will be amenable to any new virus to ensure rapid and consistent diagnostics can be performed anywhere in New Zealand within a short time-frame.